Publication | Closed Access
Intravesical Epirubicin Versus Doxorubicin for Superficial Bladder Tumors (Stages pTa and pT1): a Randomized Prospective Study
61
Citations
28
References
1997
Year
This study demonstrates that epirubicin has better efficacy and lower toxicity than doxorubicin when used as an intravesical agent.
| Year | Citations | |
|---|---|---|
Page 1
Page 1